Jan Groen

Jan Groen is the current Director at NOVIGENIX. Prior to this, they were the Chairman of the Supervisory Board at Cergentis from July 2019 to July 2022. Cergentis is a diagnostic company acquired by the Swiss based company Solvias in July 2022. From April 2010 to March 2019, Jan served as the President and CEO of MDxHealth. MDxHealth is a leading molecular diagnostic company that develops and commercializes epigenetic tests to support cancer treatment. Prior to MDxHealth, Jan served as the CEO and Founder of DxOrange and President and COO of Agendia from June 2007 to April 2010. Jan began their career in 2003 as the Vice President of Research & Development at Focus Diagnostics where they worked until 2007.

Jan Groen has a PhD in Medical Microbiology from Erasmus University Rotterdam.